CNSP
CNS Pharmaceuticals Inc
NASDAQ: CNSP · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.44% today
Updated 2026-04-30
Market cap
$1.91M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-35.75
Dividend yield
—
52W range
$2 – $17
Volume
0.0M
CNS Pharmaceuticals Inc (CNSP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-69.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+72.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+3.9%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-10.15 | -99.4% | $5.46 | $5.30 | -2.9% |
| 2025-11-14 | $-5.76 | -814.3% | $6.45 | $6.70 | +3.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-5.09 | $-10.15 | -99.4% | — | — |
| 2025-09-30 | $-0.63 | $-5.76 | -814.3% | — | — |
| 2025-06-30 | $-9.60 | $-6.42 | +33.1% | — | — |
| 2025-03-31 | $-2.00 | $-2.25 | -12.4% | $3140.00 | -50.6% |
| 2024-12-31 | $-7.33 | $-37.33 | -409.3% | $3140.00 | — |
| 2024-09-30 | $-0.10 | $-0.25 | -152.7% | — | — |
| 2024-06-30 | — | $-6.72 | — | — | — |
| 2024-03-31 | — | $-0.41 | — | $6362.00 | — |
| 2023-12-31 | — | $-28,622.96 | — | — | — |
| 2023-09-30 | $-2.40 | $-2.70 | -12.5% | — | — |
| 2023-06-30 | — | $-1.04 | — | — | — |
| 2023-03-31 | — | $-2.59 | — | — | — |
Frequently asked questions
Has CNS Pharmaceuticals Inc beaten earnings estimates?
CNS Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -69.7% over the last 4 quarters.
How does CNSP stock react to earnings?
CNSP stock has moved an average of +0.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.